Navigation Links
Fujifilm's Exclusive Software Advances Cardiovascular Reporting Capabilities
Date:3/17/2011

STAMFORD, Conn., March 17, 2011 /PRNewswire/ -- ACC Booth # 2001 -- Further enhancing its cardiovascular reporting capabilities, FUJIFILM Medical Systems U.S.A., Inc. is pleased to announce the availability of its Intelligent Structured Reporting (ISR) technology. An advanced software decision support system, ISR will be featured along with the complete line-up of Synapse® Cardiovascular products at the American College of Cardiology (ACC) 2011 Annual Scientific Session and Expo April 2nd – 5th in New Orleans, La. Available exclusively from Fujifilm, ISR is the latest addition to the Synapse® family of integrated solutions dedicated to enhancing clinical workflow and increasing diagnostic certainty.

"The number of exams and associated workload for cardiologists and sonographers has been steadily increasing, so it's our mission to provide technologies that can enable them to be more efficient," says Jim Morgan, Vice President, Medical Informatics at Fujifilm. "Synapse Cardiovascular's Intelligent Structured Reporting is proven to increase productivity for clinicians, increase the quality of echocardiography reports generated, and increase the overall level of care for patients."

ISR Equals Increased Efficiency and High Quality

ISR increases user efficiency by enabling cardiologists to read more exams in less time. It does this by incorporating an advanced tool set that directly ties echo measurement data and clinical statements to a comparative knowledge base. This helps improve the reading accuracy and report consistency when interpreting echocardiograms. Advanced capabilities of ISR include the ability to monitor input echo measurements in real-time, warn the user of inconsistencies, and automatically complete an echocardiography report based on absolute and inferred data. The application also suggests further areas of evaluation based on clinical findings and outlines a treatment consideration for the patient.

A New Era in Clinical Reporting

ISR brings a new clinical concept to echo reporting using the Agile Computing Theory. This innovative technology makes frequent, real-time updates to Synapse Cardiovascular to ensure that the cardiologist and sonographers are equipped with the latest cardiovascular information. This data is standards based and all suggestions provided by the system are directly traceable to a clinical source. The database includes thousands of peer reviewed clinical papers so cardiologists have the ability to prove statements and perform further research.

In addition to the Synapse Cardiovascular ISR technology, Fujifilm will also be featuring its full range of informatics products including Synapse® 3D and Synapse® Mobility at the 2011 ACC.  For more information on these products visit booth number 2001 or log on to www.fujimed.com.

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJINON is a subsidiary of FUJIFILM Medical Systems U.S.A., Inc., and supplies technologically advanced endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT.  For more information visit www.fujimed.com.  

© 2011 FUJIFILM Medical Systems U.S.A., Inc.  


'/>"/>
SOURCE FUJIFILM Medical Systems U.S.A., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PDI Announces Exclusive Partnership With Qforma, Leading Provider of Advanced Analytics for Health Sciences Industry
2. Argon Medical Devices Announces Exclusive License and Distribution Agreement for Option™ Retrievable Inferior Vena Cava Filter
3. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
4. Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo
5. Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market
6. Smith & Nephews Exclusive OXINIUM™ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market
7. Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products
8. OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear®
9. Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
10. BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers
11. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... 29, 2016 Glycotope GmbH, a ... announces the appointment of Dr. Alfredo Zurlo ... an oncologist with many years clinical experience and a ... His last role was at Mologen AG where he ... Board. Previously Dr. Zurlo held various positions at F ...
(Date:4/28/2016)... 2016  While Abbott,s announced purchase of St. ... repair and stent business, healthcare research firm Kalorama ... firmly into patient monitoring.  Kalorama said that patient ... areas, with double-digit growth expected the next 5 ... Remote Patient Monitoring . Abbott Laboratories agreed ...
(Date:4/28/2016)... TOKYO , April 28, 2016 /PRNewswire/ ... Ahuja , George Phillips und ... wachsenden Unternehmens    ArisGlobal®, ein ... Life Sciences, gab heute bekannt, dass neue ... wachsenden Unternehmens gestoßen sind, die vielfältige Erfahrungen ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... A new ... with severe congenital diaphragmatic hernia have better survival rates if surgery is performed ... (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs into ...
(Date:4/29/2016)... PA (PRWEB) , ... April 29, 2016 , ... ... announced that student team BioCellection won the $30,000 Perlman Grand Prize of the ... Prize, the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent Marketing ... an exercise invention which aids in proper muscle development. , "The Gym & ... Creative Director of World Patent Marketing. "Globalization has threatened the future growth of ...
(Date:4/29/2016)... ... ... the deadliest type of skin cancer. Although only about 1 percent of skin cancer cases ... 10,000 people are expected to die of melanoma this year. The risk increases with age, ... most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may give ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, 2016 , ... New York City based ... surgery . This surgery is a very effective way to treat obstructive sleep apnea. Dr. ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This ...
Breaking Medicine News(10 mins):